NCT03867734View on ClinicalTrials.gov

Aztreonam for Pharyngeal Gonorrhea

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 5, 2019

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Gonorrhea of PharynxGonorrhea
Interventions
DRUG

Aztreonam

2g IM Aztreonam

Trial Locations (1)

98104

Public Health -- Seattle & King County STD Clinic, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT03867734 - Aztreonam for Pharyngeal Gonorrhea | Biotech Hunter | Biotech Hunter